epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Duavee

estrogens, conjugated/ bazedoxifene

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Endometrial Cancer Risk

unopposed estrogen use incr. endometrial CA risk in patients with intact uterus; estrogens, conjugated/bazedoxifene has been shown to decr. risk of endometrial hyperplasia, a possible precursor to endometrial CA; use adequate diagnostic measures such as endometrial sampling to rule out malignancy if undiagnosed persistent or recurrent abnormal genital bleeding; patients should not take additional estrogens during tx

Cardiovascular and Probable Dementia Risks

estrogen should not be used for cardiovascular disease or dementia prevention; incr. risk of stroke and DVT in postmenopausal patients 50-79 yo (WHI estrogen-alone substudy regimen = conjugated estrogens 0.625 mg/day x7y); incr. risk of probable dementia in postmenopausal patients 65 yo and older (WHIMS estrogen-alone substudy regimen = conjugated estrogens 0.625 mg/day x5y); risk unknown in younger postmenopausal patients; other doses of conjugated estrogens or other estrogen-alone products not studied, therefore adverse cardiovascular events and dementia relevance is unknown; weigh risk/benefit; use lowest effective estrogen dose, shortest duration based on individual tx goals and risks

Adult Dosing .

Dosage forms:  TAB: 0.45 mg/20 mg

vasomotor symptoms, moderate-severe menopausal

[1 tab PO qd]
Info: for patients with intact uterus; use shortest effective tx duration; do not cut/crush/chew tab; D/C tx >4-6wk before surgery with VTE risk

osteoporosis prevention, postmenopausal

[1 tab PO qd]
Info: for patients with intact uterus; use shortest effective tx duration; calcium and vitamin D supplementation recommended if inadequate dietary intake; do not cut/crush/chew tab; D/C tx >4-6wk before surgery with VTE risk

renal dosing

[see below]
renal disease: not defined, caution advised
HD/PD: not defined, caution advised

hepatic dosing

[see below]
hepatic impairment: contraindicated

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@4f3efd07
  • hypersensitivity to drug or ingredient
  • vaginal bleeding, undiagnosed
  • breast CA
  • breast CA history
  • cancer, estrogen-dependent
  • cancer history, estrogen-dependent
  • venous thromboembolism
  • venous thromboembolism history
  • arterial thromboembolism within 12mo
  • protein C deficiency
  • protein S deficiency
  • thrombophilic disorder
  • hepatic disease
  • hepatic impairment
  • pregnancy
  • breastfeeding
  • caution: patients 65 yo and older
  • caution: renal disease
  • caution: cardiovascular disease
  • caution: vascular disease risk
  • caution: HTN
  • caution: diabetes mellitus
  • caution: smokers
  • caution: smoking habit change
  • caution: hypertriglyceridemia
  • caution: BMI >27 kg/m^2
  • caution: surgery
  • caution: immobilization, prolonged
  • caution: gallbladder disease
  • caution: cholestatic jaundice history, estrogen-associated
  • caution: cholestatic jaundice history, pregnancy-associated
  • caution: hypothyroidism
  • caution: sensitivity to fluid retention
  • caution: hypocalcemia, severe
  • caution: migraine
  • caution: chorea
  • caution: seizure disorder
  • caution: asthma
  • caution: porphyria
  • caution: SLE
  • caution: hepatic hemangioma
  • caution: angioedema, hereditary

Drug Interactions .

Overview

bazedoxifene

SERM

Interaction Characteristics:
  • UGT1A1 substrate
  • affected by altered enterohepatic circulation
  • estrogen modulator
  • thrombogenic effects

estrogens, conjugated (hormone replacement)

estrogen

Interaction Characteristics:
  • CYP1A2 substrate
  • CYP3A4 substrate
  • P-gp substrate
  • CYP1A2 inhibitor, moderate
  • UGT1A4 inducer
  • estrogen
  • hyperglycemic effects
  • interferes w/ ACTH analog test
  • thrombogenic effects
  • thyroid hormone synthesis/metabolism effects

Contraindicated

  • fezolinetant
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fezolinetant
    1 interaction

    Contraindicated

    estrogens, conjugated (hormone replacement) + fezolinetant

    contraindicated: combo may incr. fezolinetant levels, risk of adverse effects (hepatic metabolism inhibited)

Avoid/Use Alternative

  • alosetron
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    alosetron
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + alosetron

    use alternative: combo may incr. alosetron levels, risk of adverse effects (hepatic metabolism inhibited)

  • anastrozole
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    anastrozole
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + anastrozole

    avoid combo: combo may decr. anastrozole efficacy (antagonistic effects)

  • bazedoxifene
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    bazedoxifene
    1 interaction

    Avoid/Use Alternative

    bazedoxifene + bazedoxifene

    avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • bendamustine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    bendamustine
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + bendamustine

    consider alternatives: combo may incr. bendamustine levels, risk of serious infection, myelosuppression, other adverse effects (hepatic metabolism inhibited)

  • clomiphene
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    clomiphene
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + clomiphene

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

  • estetrol (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    estetrol (contraceptive)
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + estetrol (contraceptive)

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

    estrogens, conjugated (hormone replacement) + estetrol (contraceptive)

    avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

  • estradiol (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    estradiol (contraceptive)
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + estradiol (contraceptive)

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

    estrogens, conjugated (hormone replacement) + estradiol (contraceptive)

    avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

  • estradiol (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    estradiol (hormone replacement)
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + estradiol (hormone replacement)

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

    estrogens, conjugated (hormone replacement) + estradiol (hormone replacement)

    avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

  • estrogens, conjugated (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    estrogens, conjugated (hormone replacement)
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + estrogens, conjugated (hormone replacement)

    avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

  • estrogens, esterified (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    estrogens, esterified (hormone replacement)
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + estrogens, esterified (hormone replacement)

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

    estrogens, conjugated (hormone replacement) + estrogens, esterified (hormone replacement)

    avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

  • ethinyl estradiol (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ethinyl estradiol (contraceptive)
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + ethinyl estradiol (contraceptive)

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

    estrogens, conjugated (hormone replacement) + ethinyl estradiol (contraceptive)

    avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

  • ethinyl estradiol (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ethinyl estradiol (hormone replacement)
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + ethinyl estradiol (hormone replacement)

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

    estrogens, conjugated (hormone replacement) + ethinyl estradiol (hormone replacement)

    avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

  • exemestane
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    exemestane
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + exemestane

    avoid combo: combo may decr. exemestane efficacy (antagonistic effects)

  • letrozole
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    letrozole
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + letrozole

    avoid combo: combo may decr. letrozole efficacy (antagonistic effects)

  • ospemifene
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ospemifene
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + ospemifene

    avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)

    estrogens, conjugated (hormone replacement) + ospemifene

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

  • pirfenidone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    pirfenidone
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + pirfenidone

    avoid combo if also combined w/ mod-strong CYP2C9, CYP2C19, CYP2D6, or CYP2E1 inhibitor; otherwise, consider alternative or decr. pirfenidone dose to 534 mg tid: combo may incr. pirfenidone levels, risk of adverse effects (hepatic metabolism inhibited)

  • raloxifene
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    raloxifene
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + raloxifene

    avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)

    estrogens, conjugated (hormone replacement) + raloxifene

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

  • tamoxifen
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tamoxifen
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + tamoxifen

    avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)

    estrogens, conjugated (hormone replacement) + tamoxifen

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

  • tizanidine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tizanidine
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + tizanidine

    use alternative or monitor BP, HR: combo may incr. tizanidine levels, risk of hypotension (including orthostasis, syncope), bradycardia, CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited)

  • toremifene
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    toremifene
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + toremifene

    avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)

    estrogens, conjugated (hormone replacement) + toremifene

    avoid combo: combo may alter efficacy of both drugs, incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, antagonistic effects)

  • tranexamic acid
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tranexamic acid
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + tranexamic acid

    avoid combo: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + tranexamic acid

    avoid combo: combo may incr. risk of thromboembolism (additive effects)

  • vaccinia immune globulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    vaccinia immune globulin
    2 interactions

    Avoid/Use Alternative

    bazedoxifene + vaccinia immune globulin

    use alternative or monitor thrombosis s/sx; use lowest vaccinia immune globulin concentration and infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + vaccinia immune globulin

    use alternative or monitor thrombosis s/sx; use lowest vaccinia immune globulin concentration and infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • vorasidenib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    vorasidenib
    1 interaction

    Avoid/Use Alternative

    estrogens, conjugated (hormone replacement) + vorasidenib

    use alternative: combo may incr. vorasidenib levels, risk of adverse effects (hepatic metabolism inhibited)

Monitor/Modify Tx

  • abemaciclib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    abemaciclib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + abemaciclib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + abemaciclib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • abrocitinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    abrocitinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + abrocitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + abrocitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • acarbose
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • aflibercept
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    aflibercept
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + aflibercept

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + aflibercept

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • alogliptin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • aminocaproic acid
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    aminocaproic acid
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + aminocaproic acid

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + aminocaproic acid

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • aminophylline
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    aminophylline
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + aminophylline

    monitor theophylline levels: combo may incr. theophylline levels, risk of cardiac arrhythmias, seizures, other toxicities (hepatic metabolism inhibited; aminophylline converted to theophylline)

  • angiotensin II
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    angiotensin II
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + angiotensin II

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + angiotensin II

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • anthrax immune globulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    anthrax immune globulin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + anthrax immune globulin

    monitor thrombosis s/sx; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + anthrax immune globulin

    monitor thrombosis s/sx; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • anti-inhibitor coagulant complex
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    anti-inhibitor coagulant complex
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + anti-inhibitor coagulant complex

    monitor thrombosis s/sx, especially w/ anti-inhibitor coagulant complex dose >100 units/kg: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + anti-inhibitor coagulant complex

    monitor thrombosis s/sx, especially w/ anti-inhibitor coagulant complex dose >100 units/kg: combo may incr. risk of thromboembolism (additive effects)

  • antihemophilic factor (factor VIII)/von Willebrand factor complex
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    antihemophilic factor (factor VIII)/ von Willebrand factor complex
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + antihemophilic factor (factor VIII)/ von Willebrand factor complex

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + antihemophilic factor (factor VIII)/ von Willebrand factor complex

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • asciminib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    asciminib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + asciminib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + asciminib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • asparaginase
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    asparaginase
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + asparaginase

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + asparaginase

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • atidarsagene autotemcel
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    atidarsagene autotemcel
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + atidarsagene autotemcel

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + atidarsagene autotemcel

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • avatrombopag
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    avatrombopag
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + avatrombopag

    monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + avatrombopag

    monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • axitinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    axitinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + axitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + axitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • baricitinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    baricitinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + baricitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + baricitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • bevacizumab
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    bevacizumab
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + bevacizumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + bevacizumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • bexagliflozin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + bexagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • binimetinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    binimetinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + binimetinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + binimetinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • botulism immune globulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    botulism immune globulin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + botulism immune globulin

    monitor thrombosis s/sx; use lowest botulism immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + botulism immune globulin

    monitor thrombosis s/sx; use lowest botulism immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • brolucizumab
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    brolucizumab
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + brolucizumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + brolucizumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • bromocriptine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + bromocriptine

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • C1 esterase inhibitor
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    C1 esterase inhibitor
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + C1 esterase inhibitor

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + C1 esterase inhibitor

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • cabozantinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    cabozantinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + cabozantinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + cabozantinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • caffeine citrate
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + caffeine citrate

    monitor caffeine levels: combo may incr. caffeine levels, risk of adverse effects (hepatic metabolism inhibited)

  • calaspargase
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    calaspargase
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + calaspargase

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + calaspargase

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • canagliflozin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + canagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • carbamazepine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    carbamazepine
    2 interactions

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + carbamazepine

    monitor carbamazepine levels: combo may incr. carbamazepine levels, risk of adverse effects; may decr. estrogen levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced, P-gp-mediated transport induced)

    Caution Advised

    bazedoxifene + carbamazepine

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

  • carfilzomib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    carfilzomib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + carfilzomib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + carfilzomib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • celecoxib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    celecoxib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + celecoxib

    monitor thrombosis s/sx; use lowest effective celecoxib dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + celecoxib

    monitor thrombosis s/sx; use lowest effective celecoxib dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • chorionic gonadotropin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    chorionic gonadotropin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + chorionic gonadotropin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + chorionic gonadotropin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • clozapine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    clozapine
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + clozapine

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + clozapine

    monitor ECG, BP, HR, thrombosis s/sx; consider decr. clozapine dose: combo may incr. clozapine levels, risk of QT prolongation, cardiac arrhythmias, hypotension, bradycardia, thromboembolism, other adverse effects (hepatic metabolism inhibited, additive effects)

  • coagulation factor IX
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    coagulation factor IX
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + coagulation factor IX

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + coagulation factor IX

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor VIIa
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    coagulation factor VIIa
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + coagulation factor VIIa

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + coagulation factor VIIa

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor XIII A-subunit
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    coagulation factor XIII A-subunit
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + coagulation factor XIII A-subunit

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + coagulation factor XIII A-subunit

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • colesevelam
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    colesevelam
    2 interactions

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

    Caution Advised

    bazedoxifene + colesevelam

    caution advised: combo may decr. bazedoxifene levels, efficacy (enterohepatic circulation altered)

  • concizumab
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    concizumab
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + concizumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + concizumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • cosyntropin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    cosyntropin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + cosyntropin

    hold estrogen 4-6wk prior to test: combo may interfere with test results (estrogen may alter plasma cortisol levels)

  • cytomegalovirus immune globulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    cytomegalovirus immune globulin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + cytomegalovirus immune globulin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + cytomegalovirus immune globulin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • danazol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    danazol
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + danazol

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + danazol

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • dapagliflozin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + dapagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • darbepoetin alfa
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    darbepoetin alfa
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + darbepoetin alfa

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + darbepoetin alfa

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • deflazacort
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    deflazacort
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + deflazacort

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + deflazacort

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • desogestrel (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    desogestrel (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + desogestrel (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + desogestrel (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • deuruxolitinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    deuruxolitinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + deuruxolitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + deuruxolitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • dexamethasone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    dexamethasone
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + dexamethasone

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + dexamethasone

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. corticosteroid adverse effects; may incr. risk of thromboembolism (mechanism unknown; additive effects)

  • diclofenac
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    diclofenac
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + diclofenac

    monitor thrombosis s/sx; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + diclofenac

    monitor thrombosis s/sx; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • diclofenac topical
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    diclofenac topical
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + diclofenac topical

    monitor thrombosis s/sx; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + diclofenac topical

    monitor thrombosis s/sx; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • dienogest (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    dienogest (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + dienogest (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + dienogest (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • diflunisal
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    diflunisal
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + diflunisal

    monitor thrombosis s/sx; use lowest effective diflunisal dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + diflunisal

    monitor thrombosis s/sx; use lowest effective diflunisal dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • drospirenone (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    drospirenone (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + drospirenone (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + drospirenone (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • drospirenone (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    drospirenone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bazedoxifene + drospirenone (hormone replacement)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • dulaglutide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • eltrombopag
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    eltrombopag
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + eltrombopag

    monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + eltrombopag

    monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • empagliflozin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + empagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • epirubicin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    epirubicin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + epirubicin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + epirubicin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • epoetin alfa
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    epoetin alfa
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + epoetin alfa

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + epoetin alfa

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ertugliflozin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + ertugliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ethynodiol (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ethynodiol (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ethynodiol (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ethynodiol (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • etodolac
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    etodolac
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + etodolac

    monitor thrombosis s/sx; use lowest effective etodolac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + etodolac

    monitor thrombosis s/sx; use lowest effective etodolac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • etonogestrel (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    etonogestrel (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + etonogestrel (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + etonogestrel (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • everolimus
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    everolimus
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + everolimus

    monitor thrombosis s/sx, especially if immunosuppressant use: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + everolimus

    monitor thrombosis s/sx, especially if immunosuppressant use: combo may incr. risk of thromboembolism (additive effects)

  • exenatide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • factor XIII concentrate
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    factor XIII concentrate
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + factor XIII concentrate

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + factor XIII concentrate

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • faricimab
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    faricimab
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + faricimab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + faricimab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fedratinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fedratinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + fedratinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + fedratinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenofibrate
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fenofibrate
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + fenofibrate

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + fenofibrate

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenofibric acid
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fenofibric acid
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + fenofibric acid

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + fenofibric acid

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenoprofen
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fenoprofen
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + fenoprofen

    monitor thrombosis s/sx; use lowest effective fenoprofen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + fenoprofen

    monitor thrombosis s/sx; use lowest effective fenoprofen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • fibrinogen (human)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fibrinogen (human)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + fibrinogen (human)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + fibrinogen (human)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fitusiran
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fitusiran
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + fitusiran

    monitor antithrombin activity level, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + fitusiran

    monitor antithrombin activity level, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • flurbiprofen
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    flurbiprofen
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + flurbiprofen

    monitor thrombosis s/sx; use lowest effective flurbiprofen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + flurbiprofen

    monitor thrombosis s/sx; use lowest effective flurbiprofen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • follitropin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    follitropin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + follitropin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + follitropin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fruquintinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fruquintinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + fruquintinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + fruquintinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • glimepiride
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • hepatitis B immune globulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    hepatitis B immune globulin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + hepatitis B immune globulin

    monitor thrombosis s/sx; use lowest hepatitis B immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + hepatitis B immune globulin

    monitor thrombosis s/sx; use lowest hepatitis B immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • hydrocortisone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + hydrocortisone

    consider hydrocortisone dose adjustment: combo may decr. corticosteroid levels, efficacy (altered cortisol-binding globulin activity)

  • ibuprofen
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ibuprofen
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ibuprofen

    monitor thrombosis s/sx; use lowest effective ibuprofen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ibuprofen

    monitor thrombosis s/sx; use lowest effective ibuprofen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • immune globulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    immune globulin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + immune globulin

    monitor thrombosis s/sx; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + immune globulin

    monitor thrombosis s/sx; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • indomethacin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    indomethacin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + indomethacin

    monitor thrombosis s/sx; use lowest effective indomethacin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + indomethacin

    monitor thrombosis s/sx; use lowest effective indomethacin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • insulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + insulin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • iodixanol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    iodixanol
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + iodixanol

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + iodixanol

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • iohexol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    iohexol
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + iohexol

    if IV iohexol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + iohexol

    if IV iohexol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • iomeprol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    iomeprol
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + iomeprol

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + iomeprol

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • iopamidol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    iopamidol
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + iopamidol

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + iopamidol

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • iopromide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    iopromide
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + iopromide

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + iopromide

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • iothalamate meglumine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    iothalamate meglumine
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + iothalamate meglumine

    if IV iothalamate meglumine use, monitor thrombosis signs/symptoms; retrograde cystography and cystourethrography use OK: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + iothalamate meglumine

    if IV iothalamate meglumine use, monitor thrombosis signs/symptoms; retrograde cystography and cystourethrography use OK: combo may incr. risk of thromboembolism (additive effects)

  • ioversol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ioversol
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ioversol

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ioversol

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ketoprofen
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ketoprofen
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ketoprofen

    monitor thrombosis s/sx; use lowest effective ketoprofen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ketoprofen

    monitor thrombosis s/sx; use lowest effective ketoprofen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • ketorolac
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ketorolac
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ketorolac

    monitor thrombosis s/sx; use lowest effective ketorolac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ketorolac

    monitor thrombosis s/sx; use lowest effective ketorolac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • lamotrigine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lamotrigine
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + lamotrigine

    consider lamotrigine maint. dose adjustment, initial dose escalation unchanged; no change if also on carbamazepine, phenytoin, phenobarbital, primidone, rifampin, or ritonavir: combo may decr. lamotrigine levels, efficacy (UGT induced)

  • lazertinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lazertinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + lazertinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + lazertinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lenalidomide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lenalidomide
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + lenalidomide

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + lenalidomide

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lenvatinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lenvatinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + lenvatinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + lenvatinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • levonorgestrel (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    levonorgestrel (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + levonorgestrel (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + levonorgestrel (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • levonorgestrel (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    levonorgestrel (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bazedoxifene + levonorgestrel (hormone replacement)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • levothyroxine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + levothyroxine

    monitor thyroid fxn: combo may decr. thyroid hormone efficacy (thyroid hormone uptake altered)

  • lidocaine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + lidocaine

    monitor lidocaine levels if lidocaine antiarrhythmic use; otherwise, monitor BP, HR: combo may incr. lidocaine levels, risk of hypotension, bradycardia, other adverse effects; risk may be higher with continuous infusion or higher doses for local anesthesia (hepatic metabolism inhibited)

  • linagliptin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • liothyronine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + liothyronine

    monitor thyroid fxn: combo may decr. thyroid hormone efficacy (thyroid hormone uptake altered)

  • liraglutide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lixisenatide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • luspatercept
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    luspatercept
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + luspatercept

    if beta thalassemia use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + luspatercept

    if beta thalassemia use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lusutrombopag
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lusutrombopag
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + lusutrombopag

    monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + lusutrombopag

    monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • meclofenamate
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    meclofenamate
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + meclofenamate

    monitor thrombosis s/sx; use lowest effective meclofenamate dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + meclofenamate

    monitor thrombosis s/sx; use lowest effective meclofenamate dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • medroxyprogesterone (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    medroxyprogesterone (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + medroxyprogesterone (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + medroxyprogesterone (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • medroxyprogesterone (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    medroxyprogesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bazedoxifene + medroxyprogesterone (hormone replacement)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • mefenamic acid
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    mefenamic acid
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + mefenamic acid

    monitor thrombosis s/sx; use lowest effective mefenamic acid dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + mefenamic acid

    monitor thrombosis s/sx; use lowest effective mefenamic acid dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • megestrol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    megestrol
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + megestrol

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + megestrol

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • meloxicam
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    meloxicam
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + meloxicam

    monitor thrombosis s/sx; use lowest effective meloxicam dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + meloxicam

    monitor thrombosis s/sx; use lowest effective meloxicam dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • menotropins
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    menotropins
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + menotropins

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + menotropins

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • metformin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methoxy polyethylene glycol-epoetin beta
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    methoxy polyethylene glycol-epoetin beta
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + methoxy polyethylene glycol-epoetin beta

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + methoxy polyethylene glycol-epoetin beta

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • methyltestosterone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    methyltestosterone
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + methyltestosterone

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + methyltestosterone

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • metyrapone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    metyrapone
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + metyrapone

    D/C estrogens 5 half-lives before metyrapone test: combo may decr. metyrapone levels, efficacy; test results may be inaccurate (UGT possibly induced; antagonistic effects)

  • miglitol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • momelotinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    momelotinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + momelotinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + momelotinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • nabumetone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    nabumetone
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + nabumetone

    monitor thrombosis s/sx; use lowest effective nabumetone dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + nabumetone

    monitor thrombosis s/sx; use lowest effective nabumetone dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • naproxen
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    naproxen
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + naproxen

    monitor thrombosis s/sx; use lowest effective naproxen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + naproxen

    monitor thrombosis s/sx; use lowest effective naproxen dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • nateglinide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • necitumumab
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    necitumumab
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + necitumumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + necitumumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • nintedanib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    nintedanib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + nintedanib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + nintedanib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • norelgestromin (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    norelgestromin (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + norelgestromin (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + norelgestromin (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    norethindrone (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + norethindrone (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + norethindrone (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    norethindrone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bazedoxifene + norethindrone (hormone replacement)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • norgestimate (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    norgestimate (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + norgestimate (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + norgestimate (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • norgestrel (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    norgestrel (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + norgestrel (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + norgestrel (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • obinutuzumab
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    obinutuzumab
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + obinutuzumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + obinutuzumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • olaparib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    olaparib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + olaparib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + olaparib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • oxaprozin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    oxaprozin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + oxaprozin

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + oxaprozin

    monitor thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • pacritinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    pacritinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + pacritinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + pacritinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • pazopanib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    pazopanib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + pazopanib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + pazopanib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • pegaspargase
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    pegaspargase
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + pegaspargase

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + pegaspargase

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • phenytoin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    phenytoin
    2 interactions

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + phenytoin

    monitor phenytoin levels: combo may decr. estrogen levels, efficacy; may incr. phenytoin levels, risk of toxicity (hepatic metabolism induced, P-gp-mediated transport induced; mechanism unknown)

    Caution Advised

    bazedoxifene + phenytoin

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

  • pioglitazone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • piroxicam
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    piroxicam
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + piroxicam

    monitor thrombosis s/sx; use lowest effective piroxicam dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + piroxicam

    monitor thrombosis s/sx; use lowest effective piroxicam dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • pomalidomide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    pomalidomide
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + pomalidomide

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + pomalidomide

    monitor CBC, thrombosis s/sx: combo may incr. pomalidomide levels, risk of serious infection, myelosuppression, thromboembolism, other adverse effects (hepatic metabolism inhibited, additive effects)

  • ponatinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ponatinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ponatinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ponatinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • porfimer
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    porfimer
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + porfimer

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + porfimer

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • pramlintide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • progesterone (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    progesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bazedoxifene + progesterone (hormone replacement)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • progesterone vaginal (hormone replacement)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    progesterone vaginal (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bazedoxifene + progesterone vaginal (hormone replacement)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • propranolol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + propranolol

    monitor BP, HR: combo may incr. propranolol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • prothrombin complex concentrate (human)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    prothrombin complex concentrate (human)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + prothrombin complex concentrate (human)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + prothrombin complex concentrate (human)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ramucirumab
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ramucirumab
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ramucirumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ramucirumab

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ranibizumab
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ranibizumab
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ranibizumab

    monitor thrombosis s/sx; risk may be lower if ocular implant use: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ranibizumab

    monitor thrombosis s/sx; risk may be lower if ocular implant use: combo may incr. risk of thromboembolism (additive effects)

  • rasagiline
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + rasagiline

    adjust max rasagiline dose to 0.5 mg/day: combo may incr. rasagiline levels, risk of adverse effects (hepatic metabolism inhibited)

  • repaglinide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • Rho(D) immune globulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    Rho(D) immune globulin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + Rho(D) immune globulin

    monitor thrombosis s/sx; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + Rho(D) immune globulin

    monitor thrombosis s/sx; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • ritlecitinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ritlecitinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ritlecitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ritlecitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • romiplostim
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    romiplostim
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + romiplostim

    monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + romiplostim

    monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ropinirole
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + ropinirole

    consider decr. ropinirole dose: combo may incr. ropinirole levels, risk of adverse effects (hepatic metabolism inhibited)

  • rosiglitazone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ruxolitinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ruxolitinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ruxolitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ruxolitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ruxolitinib topical
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ruxolitinib topical
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ruxolitinib topical

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ruxolitinib topical

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • salsalate
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    salsalate
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + salsalate

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + salsalate

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • saxagliptin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • segesterone (contraceptive)
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    segesterone (contraceptive)
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + segesterone (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + segesterone (contraceptive)

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • semaglutide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sipuleucel-T
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    sipuleucel-T
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + sipuleucel-T

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + sipuleucel-T

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • sitagliptin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium tetradecyl sulfate
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    sodium tetradecyl sulfate
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + sodium tetradecyl sulfate

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + sodium tetradecyl sulfate

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • somapacitan
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    somapacitan
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + somapacitan

    incr. somapacitan start dose to 2 mg qwk: combo may decr. somapacitan efficacy (antagonistic effects, oral estrogens may reduce serum IGF-1 response)

  • somatrogon
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    somatrogon
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + somatrogon

    consider somatrogon dose adjustment: combo may decr. somatrogon efficacy (antagonistic effects, oral estrogens may reduce serum IGF-1 response)

  • somatropin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    somatropin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + somatropin

    consider incr. somatropin dose: combo may decr. somatropin efficacy (antagonistic effects, oral estrogens may reduce serum IGF-1 response)

  • sotatercept
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    sotatercept
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + sotatercept

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + sotatercept

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • sulindac
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    sulindac
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + sulindac

    monitor thrombosis s/sx; use lowest effective sulindac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + sulindac

    monitor thrombosis s/sx; use lowest effective sulindac dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • tesamorelin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tesamorelin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + tesamorelin

    monitor efficacy: combo may alter estrogen levels, incr. risk of adverse effects or decr. efficacy (hepatic metabolism possibly altered)

  • testosterone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    testosterone
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + testosterone

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + testosterone

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • thalidomide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    thalidomide
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + thalidomide

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + thalidomide

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • theophylline
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    theophylline
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + theophylline

    monitor theophylline levels: combo may incr. theophylline levels, risk of cardiac arrhythmias, seizures, other toxicities (hepatic metabolism inhibited)

  • thyroid
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + thyroid

    monitor thyroid fxn: combo may decr. thyroid hormone efficacy (thyroid hormone uptake altered)

  • tirzepatide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tivozanib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tivozanib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + tivozanib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + tivozanib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • tofacitinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tofacitinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + tofacitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + tofacitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • tolmetin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tolmetin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + tolmetin

    monitor thrombosis s/sx; use lowest effective tolmetin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + tolmetin

    monitor thrombosis s/sx; use lowest effective tolmetin dose, shortest effective tx duration: combo may incr. risk of thromboembolism (additive effects)

  • trametinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    trametinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + trametinib

    monitor thrombosis s/sx, especially in combo w/ dabrafenib: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + trametinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • tretinoin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tretinoin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + tretinoin

    monitor thrombosis s/sx, especially during 1st month of tretinoin use: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + tretinoin

    monitor thrombosis s/sx, especially during 1st month of tretinoin use: combo may incr. risk of thromboembolism (additive effects)

  • triclabendazole
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    triclabendazole
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + triclabendazole

    monitor ECG: combo may incr. triclabendazole levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (hepatic metabolism inhibited)

  • upadacitinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    upadacitinib
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + upadacitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + upadacitinib

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • vadadustat
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    vadadustat
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + vadadustat

    monitor Hgb, thrombosis s/sx; use lowest effective vadadustat dose: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + vadadustat

    monitor Hgb, thrombosis s/sx; use lowest effective vadadustat dose: combo may incr. risk of thromboembolism (additive effects)

  • valoctocogene roxaparvovec
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    valoctocogene roxaparvovec
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + valoctocogene roxaparvovec

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + valoctocogene roxaparvovec

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • valproic acid
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    valproic acid
    2 interactions

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + valproic acid

    monitor valproic acid levels: combo may decr. valproic acid levels, efficacy (UGT induced)

    Caution Advised

    bazedoxifene + valproic acid

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

  • vamorolone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    vamorolone
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + vamorolone

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + vamorolone

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • varicella zoster immune globulin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    varicella zoster immune globulin
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + varicella zoster immune globulin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + varicella zoster immune globulin

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • von Willebrand factor
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    von Willebrand factor
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + von Willebrand factor

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + von Willebrand factor

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • vorinostat
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    vorinostat
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + vorinostat

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + vorinostat

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • warfarin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    warfarin
    1 interaction

    Monitor/Modify Tx

    estrogens, conjugated (hormone replacement) + warfarin

    monitor INR, bleeding s/sx, especially during initiation/titration: combo may incr. warfarin levels, risk of bleeding (including life-threatening), other adverse effects (hepatic metabolism inhibited)

  • ziv-aflibercept
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ziv-aflibercept
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + ziv-aflibercept

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + ziv-aflibercept

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • zopapogene imadenovec
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    zopapogene imadenovec
    2 interactions

    Monitor/Modify Tx

    bazedoxifene + zopapogene imadenovec

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

    estrogens, conjugated (hormone replacement) + zopapogene imadenovec

    monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

Caution Advised

  • apalutamide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    apalutamide
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + apalutamide

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced, P-gp-mediated transport induced)

  • betamethasone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    betamethasone
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + betamethasone

    caution advised: combo may incr. corticosteroid adverse effects (mechanism unknown)

  • butalbital
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    butalbital
    2 interactions

    Caution Advised

    bazedoxifene + butalbital

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + butalbital

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced)

  • caffeine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    caffeine
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + caffeine

    caution advised: combo may incr. caffeine levels, risk of adverse effects (hepatic metabolism inhibited)

  • charcoal, activated
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    charcoal, activated
    1 interaction

    Caution Advised

    bazedoxifene + charcoal, activated

    caution advised: combo may decr. bazedoxifene levels, efficacy (enterohepatic circulation altered)

  • cholestyramine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    cholestyramine
    1 interaction

    Caution Advised

    bazedoxifene + cholestyramine

    caution advised: combo may decr. bazedoxifene levels, efficacy (enterohepatic circulation altered)

  • colestipol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    colestipol
    1 interaction

    Caution Advised

    bazedoxifene + colestipol

    caution advised: combo may decr. bazedoxifene levels, efficacy (enterohepatic circulation altered)

  • cortisone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    cortisone
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + cortisone

    caution advised: combo may incr. corticosteroid adverse effects (mechanism unknown)

  • cyclosporine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    cyclosporine
    1 interaction

    Caution Advised

    bazedoxifene + cyclosporine

    caution advised: combo may decr. bazedoxifene levels, efficacy (enterohepatic circulation altered)

  • danshen
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    danshen
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + danshen

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport induced)

  • dantrolene
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    dantrolene
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + dantrolene

    caution advised, especially in pts >35 yo: combo may incr. risk of hepatotoxicity (additive effects)

  • dicloxacillin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    dicloxacillin
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + dicloxacillin

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport induced)

  • duloxetine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    duloxetine
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + duloxetine

    caution advised: combo may incr. duloxetine levels, risk of adverse effects (hepatic metabolism inhibited)

  • efavirenz
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    efavirenz
    2 interactions

    Caution Advised

    bazedoxifene + efavirenz

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + efavirenz

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport induced)

  • elacestrant
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    elacestrant
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + elacestrant

    caution advised: combo may decr. elacestrant efficacy (antagonistic effects)

  • elagolix
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    elagolix
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + elagolix

    caution advised: combo may decr. elagolix efficacy (antagonistic effects)

  • encorafenib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    encorafenib
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + encorafenib

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced)

  • enzalutamide
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    enzalutamide
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + enzalutamide

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced)

  • fosphenytoin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fosphenytoin
    2 interactions

    Caution Advised

    bazedoxifene + fosphenytoin

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + fosphenytoin

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced, P-gp-mediated transport induced)

  • fulvestrant
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    fulvestrant
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + fulvestrant

    caution advised: combo may decr. fulvestrant efficacy (antagonistic effects)

  • grapefruit
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    grapefruit
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + grapefruit

    caution advised w/ oral estrogen: combo may incr. estrogen levels, risk of adverse effects (GI metabolism inhibited)

  • icosapent ethyl
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    icosapent ethyl
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + icosapent ethyl

    caution advised: combo may antagonize antihyperlipidemic effect of omega-3-acid (antagonistic effects)

  • imlunestrant
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    imlunestrant
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + imlunestrant

    caution advised: combo may decr. efficacy of both drugs (antagonistic effects)

  • ivosidenib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ivosidenib
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + ivosidenib

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced)

  • lorlatinib
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lorlatinib
    2 interactions

    Caution Advised

    bazedoxifene + lorlatinib

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + lorlatinib

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport induced)

  • lumacaftor/ivacaftor
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + lumacaftor/ ivacaftor

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced, P-gp-mediated transport possibly induced)

  • melatonin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    melatonin
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + melatonin

    caution advised: combo may incr. melatonin levels, risk of adverse effects (hepatic metabolism inhibited)

  • meropenem
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    meropenem
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + meropenem

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport possibly induced)

  • methylprednisolone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    methylprednisolone
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + methylprednisolone

    caution advised: combo may incr. corticosteroid adverse effects (mechanism unknown)

  • mitapivat
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    mitapivat
    1 interaction

    Caution Advised

    bazedoxifene + mitapivat

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT possibly induced)

  • mitotane
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    mitotane
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + mitotane

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced)

  • oxcarbazepine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    oxcarbazepine
    2 interactions

    Caution Advised

    bazedoxifene + oxcarbazepine

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + oxcarbazepine

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport possibly induced)

  • pentobarbital
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    pentobarbital
    2 interactions

    Caution Advised

    bazedoxifene + pentobarbital

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + pentobarbital

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced)

  • phenobarbital
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    phenobarbital
    2 interactions

    Caution Advised

    bazedoxifene + phenobarbital

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + phenobarbital

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced, P-gp-mediated transport possibly induced)

  • prednisolone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    prednisolone
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + prednisolone

    caution advised: combo may incr. corticosteroid adverse effects (mechanism unknown)

  • prednisone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    prednisone
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + prednisone

    caution advised: combo may incr. corticosteroid adverse effects (mechanism unknown)

  • primidone
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    primidone
    2 interactions

    Caution Advised

    bazedoxifene + primidone

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + primidone

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced, P-gp-mediated transport induced)

  • ramelteon
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ramelteon
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + ramelteon

    caution advised: combo may incr. ramelteon levels, risk of adverse effects (hepatic metabolism inhibited)

  • relugolix
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    relugolix
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + relugolix

    caution advised: combo may decr. relugolix efficacy (antagonistic effects)

  • rifabutin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    rifabutin
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + rifabutin

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced, P-gp-mediated transport possibly induced)

  • rifampin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    rifampin
    2 interactions

    Caution Advised

    bazedoxifene + rifampin

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + rifampin

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced, P-gp-mediated transport induced)

  • rifapentine
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    rifapentine
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + rifapentine

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport possibly induced)

  • riluzole
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    riluzole
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + riluzole

    caution advised: combo may incr. riluzole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ritonavir
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ritonavir
    2 interactions

    Caution Advised

    bazedoxifene + ritonavir

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + ritonavir

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced)

  • roflumilast
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    roflumilast
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + roflumilast

    if also combined w/ CYP3A4 inhibitor, caution advised: combo may incr. roflumilast levels, risk of adverse effects (hepatic metabolism inhibited)

  • roflumilast topical
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    roflumilast topical
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + roflumilast topical

    if also combined w/ CYP3A4 inhibitor, caution advised: combo may incr. roflumilast levels, risk of adverse effects (hepatic metabolism inhibited)

  • romidepsin
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    romidepsin
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + romidepsin

    caution advised: combo may decr. estrogen efficacy (possible antagonistic effects)

  • selegiline
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    selegiline
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + selegiline

    caution advised: combo may incr. selegiline levels, risk of adverse effects (hepatic metabolism inhibited)

  • St. John's wort
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    St. John's wort
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + St. John's wort

    caution advised: combo may decr. estrogen levels, efficacy (hepatic metabolism induced, P-gp-mediated transport induced)

  • tipranavir
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    tipranavir
    2 interactions

    Caution Advised

    bazedoxifene + tipranavir

    caution advised: combo may decr. bazedoxifene levels, efficacy (UGT induced)

    estrogens, conjugated (hormone replacement) + tipranavir

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport induced)

  • turmeric
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    turmeric
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + turmeric

    caution advised w/ oral turmeric: combo may decr. estrogen levels, efficacy (P-gp-mediated transport induced)

  • ursodiol
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    ursodiol
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + ursodiol

    caution advised: combo may decr. ursodiol efficacy (antagonistic effects, estrogens promote gallstone formation)

  • vaborbactam
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    vaborbactam
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + vaborbactam

    caution advised: combo may decr. estrogen levels, efficacy (P-gp-mediated transport possibly induced)

  • zolmitriptan
  • Duavee (estrogens, conjugated/ bazedoxifene)
    +
    zolmitriptan
    1 interaction

    Caution Advised

    estrogens, conjugated (hormone replacement) + zolmitriptan

    caution advised: combo may incr. zolmitriptan levels, risk of adverse effects (hepatic metabolism inhibited)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@65879dba
  • thromboembolism
  • retinal thrombosis
  • stroke
  • dementia
  • hypersensitivity reaction
  • anaphylaxis
  • erythema multiforme
  • pancreatitis
  • cholestatic jaundice
  • gallbladder disease
  • breast CA risk
  • ovarian CA risk

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@790dbab0
  • muscle spasms
  • nausea
  • diarrhea
  • dyspepsia
  • abdominal pain
  • oropharyngeal pain
  • neck pain
  • dizziness

Safety/Monitoring .

Monitoring Parameters
breast exam q12mo; mammography; BP; free T4, free T3 if hypothyroidism tx

Pregnancy/Lactation .

Pregnancy

Clinical Summary

N/A; drug unlikely to be used during pregnancy based on indication

Lactation

Clinical Summary

N/A; drug unlikely to be used while breastfeeding based on indication

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@7bf4b026

Metabolism: for estrogen: liver; CYP450: 3A4 (partial) substrate; Info: enterohepatically recirculated; converted to active estrogen metabolites including estradiol, estrone; for bazedoxifene: liver, GI tract; CYP450: minimal; UGT: 1A1, 1A8, 1A10 substrate; Info: undergoes enterohepatic recycling

Excretion: for estrogen: urine; Half-life: 17h (estrone); for bazedoxifene: feces 85%, urine <1%; Half-life: 30h

Subclass: Estrogen Receptor Modulators, Selective (SERMs) ; Estrogens, Non-oncologic ; Osteoporosis: Estrogenic Agents

Mechanism of Action
for estrogen: binds to estrogen receptors, developing and maintaining female sex characteristics and reproductive systems; for bazedoxifene: selectively binds to estrogen receptors, producing estrogenic and anti-estrogenic effects (estrogen receptor modulator); estrogen antagonist in uterus, decr. endometrial hyperplasia risk

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Pfizer Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@30610156

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral tablet:

  • 0.45 mg/20 mg (30 ea): $205.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information